🔎 Trials Near Me

Pradžia › 2 tipo cukrinis diabetas › Ilinoisas

2 tipo cukrinis diabetas klinikiniai tyrimai Ilinoisas

30 tyrimai dėl 2 tipo cukrinis diabetas ieško dalyvių vietose Ilinoisas.

Miestai Ilinoisas

Oficialus tyrimo tekstas (anglų kalba)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Accellacare - DuPage, Lombard
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07783802

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

  • Endeavor Health, Skokie
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Cedar Crosse Research Center, Chicago
  • Accellacare of Duly - Lombard, Lombard
  • Accellacare of Duly, Oak Lawn
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Evanston Premier Healthcare Research LLC, Skokie
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07754461

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Northwestern University, Chicago
  • Northshore University Health System, Glenview
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06112418

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • Cedar Crosse Research Center, Chicago
  • Northwestern University, Chicago
  • Endeavor Health - Family Medicine Administration, Evanston
  • ir dar 1
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  • Research Site, Champaign
  • Research Site, Chicago
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07776509

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • NorthShore University Health System, Skokie
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Chicago
  • Research Site, Melrose Park
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Schaumburg
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • AES - DRS - Synexus Clinical Research US, Inc. - Chicago, Chicago
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07340320

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

  • Cedar-Crosse Research Center, Chicago
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Research by Design, LLC - Internal Medicine, Chicago
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Melrose Park
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Chicago Clinical Research Institute, Chicago
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07296484

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • SIU Medicine, Springfield
Renkami dalyviai3 fazė
Amžius nuo 10 iki 18 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07282613

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Elevate Clinical Research, Gurnee
  • Chicago Medical Research LLC, Hazel Crest
  • Genesis Orthopedics & Sports Medicine, Oak Brook
  • ir dar 1
Renkami dalyviai3 fazė
Amžius 45 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Chicago
  • Research Site, Skokie
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT07662109

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

  • Research Site, Melrose Park
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT07606066

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • University of Illinois at Chicago, Chicago
Renkami dalyviai3 fazė
Amžius nuo 10 iki 17 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06739122

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Northwestern University, Chicago
Renkami dalyviai
Amžius nuo 14 iki 75 · Visoms lytims · Atnaujinta 2026-08-03 · NCT07579702

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  • Northwestern University, Chicago
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-03 · NCT07521475

Achieving Routine Intervention and Screening for Emotional Health

  • University of Chicago, Chicago
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-08 · NCT06887049

Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes

  • Illinois Institute of Technology, Chicago
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-16 · NCT07650682

Exercise and Protein Efficiency in T2D

  • Freer Hall - University of Illinois, Urbana
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2026-04-29 · NCT07477067

Enhancing Diabetes Care: Exposome &Amp; Sensors

  • University of Illinois - Chicago, Chicago
  • University of Illinois College of Nursing, Chicago
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2025-05-25 · NCT06989008

My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes

  • University of Illinois at Chicago, Chicago
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 21 iki 75 · Visoms lytims · Atnaujinta 2025-03-05 · NCT05208164

RCT Glargine vs NPH for Treatment of DM in Pregnancy

  • Loyola University Medical Center, Maywood
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2024-10-01 · NCT06619301

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.